<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="47450">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02488486</url>
  </required_header>
  <id_info>
    <org_study_id>2014/24</org_study_id>
    <secondary_id>2014-A00949-38</secondary_id>
    <nct_id>NCT02488486</nct_id>
  </id_info>
  <brief_title>Postoperative Sedation After Cardiac Surgery</brief_title>
  <acronym>SEDCAR</acronym>
  <official_title>Postoperative Sedation After Cardiac Surgery: Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This pilot study evaluates the effectiveness of a closed-loop administration of propofol and
      remifentanil guided by the bispectral index for short-term sedation after cardiac surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Level of sedation</measure>
    <time_frame>6 hours</time_frame>
    <description>Richmond Agitation-Sedation Scale measured until extubation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Level of pain during sedation</measure>
    <time_frame>6 hours</time_frame>
    <description>Behavioral Pain Scale measured until extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in hemodynamics profile consecutive to a tracheal suctioning</measure>
    <time_frame>6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Bispectral Index consecutive to a tracheal suctioning</measure>
    <time_frame>6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Richmond Agitation-Sedation Scale consecutive to a tracheal suctioning</measure>
    <time_frame>6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Behavioral Pain Scale consecutive to a tracheal suctioning</measure>
    <time_frame>6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in concentration of propofol consecutive to a tracheal suctioning</measure>
    <time_frame>6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in concentration of remifentanil consecutive to a tracheal suctioning</measure>
    <time_frame>6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delay before awakening</measure>
    <time_frame>6 hours</time_frame>
    <description>Delay between the cessation of infusion of propofol and remifentanil and extubation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of temporary or definitive interruptions of the automated administration of propofol and remifentanil</measure>
    <time_frame>6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Calculation of indices of performance of the closed-loop system</measure>
    <time_frame>6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Periods of electrical silence</measure>
    <time_frame>6 hours</time_frame>
    <description>Number and duration of electroencephalographic periods of silence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total amounts of propofol observed during sedation period</measure>
    <time_frame>6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total amounts of remifentanil observed during sedation period</measure>
    <time_frame>6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in calculated plasma concentrations of propofol including minimum concentrations and maximum values</measure>
    <time_frame>6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in calculated plasma concentrations of remifentanil including minimum concentrations and maximum values.</measure>
    <time_frame>6 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic status during the sedation period</measure>
    <time_frame>6 hours</time_frame>
    <description>Evolution of hemodynamic parameters (composite)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic status during the sedation period</measure>
    <time_frame>6 hours</time_frame>
    <description>Number of medical interventions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of consciousness after extubation</measure>
    <time_frame>6 hours</time_frame>
    <description>Richmond Agitation-Sedation Scale assessed every hour for three hours after extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain after extubation</measure>
    <time_frame>6 hours</time_frame>
    <description>Simple numerical scale from 0 (no pain) to 10 (worst possible) assessed every hour for three hours after extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Awareness standardized questionnaire</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">53</enrollment>
  <condition>Surgery, Cardiac</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Automated postoperative sedation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Postoperative sedation is provided automatically using a closed-loop system. Bispectral index is used as the input signal and an algorithm defines the appropriate concentrations of propofol and remifentanil. Adequate postoperative sedation is defined by a bispectral index between 40 and 60.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Automated postoperative sedation</intervention_name>
    <arm_group_label>Automated postoperative sedation</arm_group_label>
    <other_name>algorithm is the property of Medsteer SAS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <arm_group_label>Automated postoperative sedation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>remifentanil</intervention_name>
    <arm_group_label>Automated postoperative sedation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  consent for participation

          -  cardiac surgical procedure requiring postoperative sedation

        Exclusion Criteria:

          -  pregnant women,

          -  neurological or muscular disorder

          -  high risk of revision surgery

          -  patients having required a redo operation if the postoperative period of sedation was
             less than 2 hours
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marc Fischler, MD</last_name>
    <phone>46252442</phone>
    <phone_ext>00331</phone_ext>
    <email>m.fischler@hopital-foch.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinique Ambroise Par√©</name>
      <address>
        <city>Neuilly-sur-Seine</city>
        <state>Hauts-de-Seine</state>
        <zip>92200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Squara, MD</last_name>
      <phone>0826200300</phone>
      <email>pierre.squara@orange.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Le Guen M, Liu N, Bourgeois E, Chazot T, Sessler DI, Rouby JJ, Fischler M. Automated sedation outperforms manual administration of propofol and remifentanil in critically ill patients with deep sedation: a randomized phase II trial. Intensive Care Med. 2013 Mar;39(3):454-62. doi: 10.1007/s00134-012-2762-2. Epub 2012 Dec 6.</citation>
    <PMID>23223772</PMID>
  </reference>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 2, 2016</lastchanged_date>
  <firstreceived_date>June 26, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
